Table 3.
Proliferative levels of PBMCs after specific and non‐specific stimulus.
| Total proliferation (%) | Treg proliferation (%) | |||||
|---|---|---|---|---|---|---|
| Stimulus | Patients | Controls | P | Patients | Controls | P |
| PHA | 47·95 ± 32·42 | 44·41 ± 20·71 | 0·710 | 6·45 ± 16·07 | 14·62 ± 16·44 | 0·218 |
| Cysticercal vesicular extract | 24·10 ± 31·28 | 4·79 ± 5·96 | 0·024* | 0·11 ± 0·17 | 0·34 ± 0·76 | 0·336 |
| Cysticercal total extract | 22·98 ± 30·53 | 5·49 ± 3·80 | 0·046* | 0·36 ± 0·55 | 1·05 ± 1·74 | 0·236 |
a
Significantly different between neurocysticercosis (NC) patients and controls with 95% confidence. PHA = phytohaemagglutinin; Treg = regulatory T cell.